Get the Stockscreener App
87.10
0.57%
-0.50
Pre-market:
87.23
0.13
+0.15%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $87.10, with a volume of 8.68M.
It is down -0.57% in the last 24 hours and down -6.36% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$87.60
Open:
$87.685
24h Volume:
8.68M
Relative Volume:
1.15
Market Cap:
$111.40B
Revenue:
$407.94B
Net Income/Loss:
$2.90B
P/E Ratio:
38.25
EPS:
2.2771
Net Cash Flow:
$7.39B
1W Performance:
-7.82%
1M Performance:
-6.36%
6M Performance:
+21.85%
1Y Performance:
+15.93%
1-Day Range:
$86.68
$88.28
1-Week Range:
$86.68
$94.95
52-Week Range:
$69.51
$110.68
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
87.10 | 121.07B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
372.95 | 340.27B | 450.13B | 14.91B | 23.62B | 15.55 |
ELV
Elevance Health Inc
|
402.43 | 90.81B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
273.74 | 74.19B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
372.00 | 49.21B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-14-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
CVS Health stock closes lower at the close - AD HOC NEWS
State Street Corp Boosts Stake in CVS Health Corporation $CVS - MarketBeat
Value-based care is hard, but it’s worth getting right - CVS Health
UBS reiterates CVS Health stock rating citing no new surprises - Investing.com
CVS Health stock trades at USD 87.60 as guidance rises - AD HOC NEWS
CVS Health (NYSE:CVS) Faces Healthcare Execution As Defensive Sectors Draw - Kalkine Media
CVS Health’s Yield Touched 3% as the Stock Slid. Is the Payout a Bargain or a Warning? - Yahoo Finance
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
CVS Health Corp. stock underperforms Monday when compared to competitors - MarketWatch
Judge approves bankruptcy plan for CVS’ Omnicare - Modern Healthcare
Here's What Might Affect CVS Health's 2026 Financial Outlook - Barchart.com
CVS Health Corp stock gains analyst support as oncology initiative advances - AD HOC NEWS
Top 3 Health Care Stocks That May Rocket Higher In September - benzinga.com
Judge approves CVS unit Omnicare’s bankruptcy plan - Yahoo Finance
CVS Health Corp. stock gains on strong earnings and analyst upgrade - AD HOC NEWS
CVS Health (NYSE:CVS) Raised to "Strong-Buy" at Wall Street Zen - MarketBeat
CVS Health Corp (NY: CVS - The Chronicle-Journal
What’s Really Driving the CVS Health (NYSE:CVS) Value Stocks Story? - Kalkine Media
CVS Health Corp. stock underperforms Friday when compared to competitors - MarketWatch
Should You Buy CVS Stock For The Margin Aetna Is Rebuilding? - trefis.com
CVS Health Corp. stock edges lower as valuation questions grow after Omnicare sale and cancer care e - AD HOC NEWS
CVS Health Corp. stock underperforms Thursday when compared to competitors - MarketWatch
CVS Unit Omnicare Bankruptcy Plan Approved After Sale, DOJ Deal - Bloomberg Law News
CVS Health's Aetna Aims To Reduce Admin Tasks For Cancer CareCVS Health (NYSE:CVS) - benzinga.com
Aetna expands oncology prior authorization bundles - CVS Health
CVS Health Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
CVS Health launches national "Wear Your HeART" Bandage Art Contest - CVS Health
Four artists could win $5,000 and see their art on CVS bandages - Stock Titan
What Does CVS Health (CVS) Updated COVID Vaccine Rollout Mean For Patients? - Yahoo Finance
CVS Health Corp. stock outperforms competitors despite losses on the day - MarketWatch
Healthy aging starts with understanding your whole health: A Q&A with Dr. Heidi Schwarzwald - CVS Health
Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth - Yahoo Finance
CVS Health Corporation $CVS Shares Sold by Corient Private Wealth LP - MarketBeat
CVS Health Corporation $CVS Stake Increased by The Manufacturers Life Insurance Company - MarketBeat
Engineers Gate Manager LP Reduces Position in CVS Health Corporation $CVS - MarketBeat
CVS Health (NYSE:CVS) Cut to Buy at Wall Street Zen - MarketBeat
CVS Renews Bid To Escape Investors' AI Use Suit - Law360
CVS Health Corp. stock gains analyst support as Overweight rating and higher targets reinforce recov - ad-hoc-news.de
What is moving CVS Health (NYSE:CVS) shares in today's market? - Kalkine Media
Cantor Fitzgerald reiterates CVS Health stock rating on Stars outlook - investing.com
CVS Health Corporation $CVS Shares Bought by Tidal Investments LLC - MarketBeat
NewEdge Advisors LLC Purchases 51,116 Shares of CVS Health Corporation $CVS - MarketBeat
Allworth Financial LP Cuts Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation (NYSE:CVS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Building a culture of support at CVS Health Corp. - Providence Business News
CVS Health stock heads into the open after a modest September 10 gain - ad-hoc-news.de
Is CVS Health (CVS) Still Undervalued After Its Wells Fargo Healthcare Conference Update? - simplywall.st
CVS Health stock holds gains after UBS cuts target - ad-hoc-news.de
Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth? - Yahoo Finance
Updated COVID-19 Vaccines Available at CVS Pharmacy and MinuteClinic Across the U.S. - csrwire.com
CVS Health redevelops soccer pitch alongside Seattle Reign FC and the RAVE Foundation - CVS Health
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cvs Health Corp Stock (CVS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ROBBINS LARRY | Director |
May 19 '26 |
Sale |
94.45 |
1,983,538 |
187,341,308 |
6,213,261 |
| ROBBINS LARRY | Director |
May 20 '26 |
Sale |
93.82 |
1,018,000 |
95,510,822 |
5,195,261 |
| ROBBINS LARRY | Director |
May 21 '26 |
Sale |
93.45 |
370,462 |
34,619,007 |
4,824,799 |
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):